ALK and lung adenocarcinoma: For ALK‐positive lung adenocarcinoma patients, univariate analyses revealed that age (p = 0.016), T stage (p = 0.008), N stage (p = 0.001), and AJCC stage (p < 0.001) were statistically significant predictors of tumor‐specific survival (Table 3).